摘要
目的：探讨充血性心力衰竭伴室性心律失常患者应用胺碘酮的临床效果及安全性。方法回顾分析本院于2010年1月~2012年12月应用胺碘酮治疗的49例充血性心力衰竭并发室性心律失常患者临床资料，在常规治疗心力衰竭的基础上先给予胺碘酮75 mg加入5%葡萄糖250 ml静脉滴注1次，然后改为胺碘酮片，待心室率下降或转复后减量维持。结果49例患者中有效29例，显效12例，无效8例，总有效率为83.6%。无严重心律失常等并发症出现。结论胺碘酮可以有效控制充血性心力衰竭并发室性心律失常患者的心室率，同时可以使部分患者转复，临床应用安全、值得临床推广。
Objective To explore the clinical efficacy and safety of congestive heart failure and ventricular arrhythmia patients treated with amiodarone. Methods Retrospective analysis of our hospital in 2010 January to December 2012 year in the use of amiodarone therapy in 49 patients with congestive heart failure and ventricular arrhythmia in patients with clinical data, based on conventional treatment of heart failure before amiodarone 75mg in 5 glucose intravenous infusion of 250ml-1, and then changed to amiodarone for ventricular rate, decreased or cardioversion after the reduction maintenance. Results In 49 patients, 29 cases were effective, 12 cases markedly effective, 8 cases ineffective, the total effective rate was 83.6 percent. No severe complications such as arrhythmia. Conclusion Amiodarone can effectively control the congestive heart failure and ventricular arrhythmia in patients with ventricular rate, also can make some patients cardioversion, safe clinical application, is worth the clinical promotion.
出处
《中国实用医药》
2014年第4期26-27,共2页
China Practical Medicine
关键词
胺碘酮
充血性心力衰竭
室性心律失常
临床疗效
Amiodarone
Congestive heart failure
Ventricular arrhythmia
Clinical curative effect
